{
  "name" : "dacemirror.sci-hub.se_journal-article_9734fd6e29ae15f942375012cde09c2f_yu2019.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Near-Infrared-Light Activatable Nanoparticles for Deep- Tissue-Penetrating Wireless Optogenetics",
    "authors" : [ "Nuo Yu", "Ling Huang", "Yubin Zhou", "Tian Xue", "Zhigang Chen", "Gang Han" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "www.advhealthmat.de\nREVIEW\n1801132 (1 of 11) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim"
    }, {
      "heading" : "Near-Infrared-Light Activatable Nanoparticles for Deep-",
      "text" : ""
    }, {
      "heading" : "Tissue-Penetrating Wireless Optogenetics",
      "text" : ""
    }, {
      "heading" : "Nuo Yu, Ling Huang, Yubin Zhou,* Tian Xue,* Zhigang Chen,* and Gang Han*",
      "text" : "DOI: 10.1002/adhm.201801132\n1. Introduction\nOptogenetics is an emerging technology that uses genetically encoded proteins to dissect cellular functions, gene expression, and protein interaction, opening new opportunities for the study of brain mapping, retinal prosthesis, and neuronal disorders (e.g., Parkinson’s disease) that cannot be satisfactorily achieved by conventional pharmacological and genetic modality.[1] Optogenetic tools are blessed with exceptional spatiotemporal precision and sensitivity through light-controlled intracellular signal transduction, as the light can be turned on or off instantaneously and can also be directed to specific subcellular locations with tunable wavelength and intensity. One prerequisite to the practice of optogenetics is to develop various kinds of optogenetic tools. In 1971, action potential simulation in Aplysia ganglia were first demonstrated using a high power blue laser.[2] In 2003, a great breakthrough for optogenetic control of mammalian neurons was achieved use of a light-sensitive ion channel, Channel-\nrhodopsin-2 (ChR2).[3] Unfortunately, these optogenetic tools usually rely on visible light (e.g., blue or yellow) with shallow tissue penetration, thus requiring the insertion of invasive fiber-optic probes into organs and tissues for signal stimulation in animals. Further attempts include the implantation of micro light-emitting diodes (µ-LEDs) inside tissue,[4] and the design of a red-shifted variant of channelrhodopsin (ReaChR),[5] which are still not ideal in regard to limitations related to penetration depth and safety issues. Therefore, it is highly desirable to develop optogenetic tools with an excitation wavelength that possesses much deeper tissue penetration ability and biocompatibility.\nNear-infrared (NIR) light with the wavelength of 700–1000 nm has been considered to be a biological transparency window that exhibits greater tissue penetration depth and minimal photodamage to tissue since such light has less absorption and less scattering within biological tissue.[6] Given these advantages, NIR-responsive molecules, organic polymers, and inorganic nanomaterials have been designed and synthesized, and these materials consequently have a variety of bioapplications, ranging from bioimaging (such as optical and photoacoustic imaging), therapies (photothermal therapy, photodynamic therapy, and so on), to that of controlled drug\nOptogenetics has been developed to control the activities and functions of cells with high spatiotemporal resolution, cell-type specificity, and flexibility. However, current optogenetic tools generally rely on visible light (e.g., blue or yellow) with shallow tissue penetration ability that does require invasive fiber-optic probes to deliver visible light into organs and animal tissues. This often results in a series of side effects, such as tissue damage and unwanted inflammation. Fortunately, the emerging wireless optogenetic tools that can respond to deep-tissue-penetrating near-infrared (NIR) light have attracted increasing attention due to their much-reduced damage to living organisms. There are mainly two types of NIR-activatable optogenetic tools: one uses lanthanide-doped upconversion nanoparticles to transduce NIR light to visible light to modulate classical opsin-expressing neurons; the other type couples with an NIR absorber to convert NIR light to heat to activate thermosensitive proteins. These NIR-activatable optogenetic tools enable low-invasive “remote control” activation and inhibition of cellular signaling pathways. This approach has great potential to help create more innovative therapies for diseases like cancer, diabetes, and neuronal disorders in the near future. Therefore, this review article summarizes the recent advances on design strategies and synthetic methods of NIR-activatable nanomaterials for wireless optogenetic applications."
    }, {
      "heading" : "Wireless Optogenetics",
      "text" : "N. Yu, Dr. L. Huang, Prof. G. Han Department of Biochemistry and Molecular Pharmacology University of Massachusetts Medical School Worcester, MA 01605, USA E-mail: Gang.Han@umassmed.edu N.Yu, Prof. Z. G. Chen State Key Laboratory for Modification of Chemical Fibers and Polymer Materials College of Materials Science and Engineering Donghua University Shanghai 201620, China E-mail: zgchen@dhu.edu.cn Prof. Y. Zhou Texas A&M Institute of Biosciences & Technology 2121 W Holcombe Blvd. Houston, TX 77030, USA E-mail: yzhou@ibt.tamhsc.edu Prof. T. Xue School of Life Science University of Science & Technology of China 443 Huangshan Street, Hefei City, Anhui 230027, China E-mail: xuetian@ustc.edu.cn\nThe ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/adhm.201801132.\nAdv. Healthcare Mater. 2019, 1801132\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (2 of 11)\ndelivery.[7] Thus, among other applications, NIR-activatable optogenetic tools have been of major interest.\nTo this point, NIR-activatable optogenetic tools can mainly be divided into two categories regarding to different mechanisms (Figure 1). The first category is lanthanide-doped upconversion nanoparticles (UCNPs), which act as the NIR light transducer. Upon NIR light irradiation, UCNPs can transduce NIR light energy to visible light emission to activate classical optogenetic opsins, which can subsequently open ion channel pores within cellular membrane, leading to the membrane depolarization or hyperpolarization to induce either activation or suppression of cellular signaling (e.g., neural action potential). As a matter of fact, in addition to the commonly used ChR2, there are a variety of other opsins that can be tailored to different wavelengths of visible light in regard to controlling the influx and outflow of charged ions, such as Ca2+, Na+, and K+, enabling the modulation of various cell signaling.[8] The other type is based on NIR-responsive photothermal absorbers that can produce local heat to activate thermosensitive protein. When exposed to NIR irradiation, such photothermal agents can convert the NIR light energy into heat, which triggers thermosensitive protein in cell membranes to open ion channels. In this review, we summarize the recent achievements with respect to these two types of NIR-activatable optogenetic tools, focusing on the design strategies, synthetic methods, cell membrane interactions, and their ability to activate and modulate cell signaling pathways (Table 1). Together with a consideration of future optimization, this review will serve to introduce the development of such innovative NIR-activatable optogenetic tools and accelerate their usage in biomedical applications."
    }, {
      "heading" : "2. UCNP-Mediated NIR-Activatable Optogenetics",
      "text" : "UCNPs that incorporate real ladderlike energy levels of trivalent rare-earth ions in an appropriate host lattice can realize frequency upconversion of low-energy incident NIR photons into high-energy visible emission.[9] UCNPs involve virtual intermediate energy levels with efficiency orders of magnitude that are higher than the conventional multiphoton processes, endowing them with the ability of being excited by a low-cost continuouswave (CW) diode laser at low-energy power. Moreover, with the versatile doping strategies, the upconversion emission of UCNPs can be easily and precisely manipulated by choosing the types and amounts of lanthanide ions, which matches the activation wavelength of different opsins. For instance, the incorporation of Yb3+-Tm3+ ions leads to blue emission that is compatible with the activation of ChR2.[9a] Therefore, UCNPs can be seen as one of the most promising optogenetical tools that can be excited by NIR light.\nIn this regard, the Han and co-workers synthesized UCNPs and further achieved significantly enhanced upconversion luminescence and a broadened absorption range through a dyesensitizing strategy (Figure 2).[10] As a result, under the irradiation of 800 nm laser, these NIR dye-sensitized UCNPs (IR806-sensitized β-NaYF4:20%Yb3+, 2%Er3+@β-NaYF4:10%Yb3+) had emissions in the visible region that overlap with the activation wavelengths of optogenetic opsins (e.g., ReaChR). These NIR dye-sensitized UCNPs were then encapsulated into\nYubin Zhou is an associate professor and American Cancer Society Research Scholar at the Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University. His research interests focus on calcium channels, optogenetics, chemical biology, and epigenome editing.\nTian Xue joined the University of Science and Technology of China (USTC) in 2012. Currently, he is a professor in the School of Life Science at USTC and the National Laboratory for Physical Sciences at Microscale. His present research is focused on sensory neuroscience in regard to peripheral photoreceptors and the central\nnervous system and regenerative approaches to vision repair.\nGang Han joined the faculty of the University of Massachusetts-Medical School (UMMS) in 2010. He is currently an associate professor in the Biochemistry and Molecular Pharmacology Department at the University of Massachusetts-Medical School. His current research interests focus on the investigation of luminescent\nmolecules and nanoparticles for biophotonic and photonic applications.\npoly(methyl methacrylate) (PMMA) polymers in order to fabricate an implantable film that was then placed directly beneath a glass coverslip containing ReaChR opsin-expressed hippocampal neurons. Interestingly, when exposed to 800 nm NIR laser, neurons are able to be spatiotemporally activated to show consistent depolarization in a light intensity-dependent manner and the action potential firing. However, this kind of UCNPbased optogenetic tool was only applied to activate neuron cells in this article. Considering the diversity of applications (such as killing cancer cells and activation of immune cells) which use different ways to communicate and transmit signals, it is essential to make this optogenetic tool more adaptive. Nevertheless, this work illustrated in a novel manner that the optogenetic\nAdv. Healthcare Mater. 2019, 1801132\nneuron excitation window can be shifted from the conventionally visible light region to a deep tissue penetrable NIR wavelength by employing NIR dye-sensitized UCNPs.\nAfter demonstrating the NIR activation of the cultured neurons using UCNPs, Han and co-workers have further combined UCNP with the Ca2+ release-activated Ca2+ (CRAC) channel, so as to develop an NIR-stimulable optogenetic platform (termed “Opto-CRAC”) (Figure 3).[11] In this application, the NaYF4:Yb,Tm/NaYF4 core/shell nanoparticles exhibited a strong emission band that was centered at 476 nm upon the 980 nm laser excitation, which partly matches the absorption of the photoswitch LOV2 (light, oxygen, voltage) domain. The UCNPs were then modified with streptavidin (UCNPs-Stv); a genetically encoded streptavidin-binding tag (StrepTag) was genetically inserted into a calcium release-activated calcium channel protein 1 (ORAI1) channel; and the interaction between UCNPs-Stv and ORAI1 channel was used to recruit UCNPs onto the cell surfaces. Fluorescence images confirmed the significant accumulation of\nUCNPs-Stv on the plasma membrane, indicating the specific targeting ability of UCNPs-Stv. The Opto-CRAC platform is based on a CRAC channel with engineered visible light sensitivity and its subsequent coupling to cell-targeted UCNPs with the ability to convert NIR light to visible light. Under the illumination of 980 nm NIR light, Ca2+ gate-controlling protein in genetically engineered immune cells were activated in order to open the calcium ion gates, resulting in the influx of extracellular Ca2+.\nFurthermore, the Opto-CRAC system was applied in immunomodulatory function in vivo for the first time. Dendritic cell (DC)-mediated immunotherapy in the B16-OVA mouse model of melanoma was carried out, and the ovalbumin (OVA) served as a surrogate tumor antigen. Typically, upon NIR irradiation, Ca2+ influx in Opto-CRAC DC prompts immature DC maturation and OVA antigen cross-presentation. This then activated CD8 T cells and expanded the cytotoxic T lymphocyte (CTLs) population for the enhanced killing of melanoma cells. To validate the immunomodulatory effect in vivo, B16-OVA murine\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (4 of 11)\nmodel of melanoma were injected with UCNPs-Stv/OVA loaded Opto-CRAC DCs. Apparently, the tumor growth was inhibited and metastasis in the lung was significantly suppressed. Certainly, this work set the stage for remote optogenetic immunomodulation and cellular immunotherapy with several distinctive advantages.\nFollowing such in vivo work, recently, the McHugh and co-workers reported that UCNPs can take optogenetic control of deep brain neurons upon pulsed NIR irradiation placed 2 mm above the skull of mice (Figure 4).[9a] In this study, silica-coated UCNPs were chosen, which have been reported to be chemically stable and the silica shell prevented UCNP core from direct contact with cells. With respect to deep brain stimulation, the ventral tegmental area (VTA) in tyrosine hydroxylase (TH)-driven Cre recombinase (TH-Cre) transgenic mice was injected with an adenoassociated virus (AAV) encoding ChR2-EYFP protein, which could lead to Cre-dependent expression of ChR2 in dopamine (DA) neurons. After four weeks, such silica-coated UCNPs were bilaterally injected into the VTA, and anaesthetized mice were irradiated by a pulse laser. Since c-fos is expressed when neurons fire action potential, expression of c-fos protein has been used as a marker for neuronal activity following optogenetic stimulation. In this study, a significantly higher proportion of c-FOS-positive cells were identified only for UCNP-injected ChR2-transfected mice under NIR light irradiation in the VTA, which is the origin of the dopaminergic cell bodies. On the other hand, no obvious c-FOS expression was reported to be observed in the control cohorts, including those injected with UCNP only, CHR2 expression only, or with\nNIR irradiation alone. This revealed that DA neuronal excitation was only triggered by NIR laser in ChR2-transfected mice with the aid of UCNPs. Furthermore, the in vivo inhibition of hippocampal activity by archaerhodopsin was also explored. The UCNPs with green light emission that overlaps with the absorption of archaerhodopsin were injected into the hippocampus (HIP) of the mice. As a result, in response to NIR stimulation, a significant decrease in c-Fos expression was demonstrated in the granule cells, confirming the effective silencing of hippocampal neurons. Next, blue-emitting UCNPs were administrated to the medial septum (MS), which induced the hippocampal theta oscillation in a frequency-dependent manner under NIR stimulation. This result confirmed the synchronization of neural activity by UCNPmediated optogenetics. Subsequently, blue-emitting UCNPs were also injected into hippocampal dentate gyrus regions to reactivate labeled granule cells which involves in memory recall. The increased freezing behavior of the mice was reported during laser illumination. Although the relatively high laser power density and close proximity between the laser light and the mice skull are still necessary, this study validates and shows the promise in using UCNPs as a less invasive deep brain stimulation approach."
    }, {
      "heading" : "3. The NIR-Induced Photothermal Activation of Optogenetics",
      "text" : "NIR-induced photothermal conversion is based on NIR absorbers (also known as photothermal agents) that can absorb\nAdv. Healthcare Mater. 2019, 1801132\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (5 of 11)\ndeep-tissue penetrable NIR light and transform it into local heat for rapid temperature elevation. Currently, various kinds of photothermal agents have been synthesized, including small molecules, such as indocyanine green dye, organic polymers (polyaniline, polypyrrole, and dopamine nanoparticles, et al.), carbon-based materials (carbon nanotube, graphene, and so on), noble metals (such as Au nanorods), and semiconductors (Cu2-xS, WO3-X, et al.).[7a,12] These photothermal agents exhibit broad and adjustable NIR absorption bands that can be excited by different wavelengths of NIR light. In addition, they can be readily modified into multifunctional photothermal platforms. Hence, these photothermal agents are of considerable interest in regard to the preparation of wireless light activation tools to regulate cellular signaling when in conjugation with the engineered thermosensitive proteins.\nFor example, the Wnt/β-cat signaling pathway is one of the fundamental mechanisms that direct cell proliferation, cell polarity, and cell fate determination during embryonic development and tissue homeostasis.[10,14] In order to regulate the Wnt/β-cat signaling pathway in mammalian cells, Bugaj et al. first proposed an optogenetic method based on Arabidopsis thaliana cryptochrome 2 (CRY2) for protein oligomerization in a rapid and reversible manner.[14] However, the optogenetic\nconstructs in this method only responds to blue light rather than deep-tissue penetrating NIR light. Therefore, Ambrosone et al. designed a NIR-triggered drug-release microcapsule to exploit the activation of the Wnt/β-cat signaling pathway in Hydra (Figure 5).[13] The polyelectrolyte multilayer microcapsule contains the Wnt/β-cat signaling pathway modulator alsterpaullone (ALP) and the agglomerated gold nanoparticles were enclosed in these microcapsules. When these microcapsules were delivered into cells, Au nanoparticles transduced NIR light to local heat, disrupting the temperature-sensitive polyelectrolyte multilayer, causing the ALP release. Then, ALP binded to glycogen synthase kinase-3β (GSK-3β) to inhibit the activity of the resultant destructive complex, so as to stabilize βcat in the cytoplasm. Subsequently, the stabilized β-cat entered the nucleus in order to interact with TCF/LEF transcription factor, ensuring the efficient transcriptional activation of downstream genes.\nInterestingly, a NIR laser with a focused light spot of ≈3 µm2 was used to excite single capsules so the ALP release was able to be confined to restricted regions in order to cause the forced activation of the Wnt pathway on a small area of a body column of the Hydra. At 72 h after the different treatments, no phenotype was observed in Hydra incubated with (PSS/PAH)6-ALP\nAdv. Healthcare Mater. 2019, 1801132\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (6 of 11)\nor (PSS/PAH)6-AuNP-ALP in the absence of NIR laser irradiation. In contrast, it was remarkable that the polyps showed the appearance of ectopic tentacles along the body column, undoubtedly confirming the successful activation of the Wnt pathway through NIR-triggered ALP release. Therefore, this work verifies the feasibility of activating the Wnt pathway in a confined area, which can inspire the development of NIR-triggered nanocapsules. It should be noted that the observed phenotype may result from Wnt pathway activation on a wider area than the actual spot size due to the thermal rupture of some other adjacent capsules. Thus a dedicated equipment may be needed for higher spatiotemporal control of cellular signaling in the future.\nIn addition to the metallic Au nanomaterials, semiconductor polymers are also well-known photothermal transducers. In this regard, the Pu and co-workers research groups reported on novel NIR-absorbing semiconducting polymer bioconjugates (SPNsbc), as demonstrated in Figure 6.[15] Compared to gold nanorods (GNR), SPNsbc bypassed the issue of metal ion induced toxicity and took advantage of superior photothermal conversion efficiency, more rapid heating capability, as well as excellent photothermal stability. The SPNsbc demonstrated a specific photothermal activation of neurons by targeting transient the receptor potential cation channel subfamily V\nmember 1 (TRPV1). TRPV1 is an ion permeable polymodal channel expressed in the mammalian nervous system that can be used as a thermosensitive channel for precisely modulating Ca2+ influx in neuronal cells. To investigate the NIR activation capacity of SPNsbc on TRPV1, ND7/23 cells and HeLa cells were respectively used as the TRPV1 positive and the negative cells. The intracellular concentration of Ca2+ was then monitored in real-time by using Fluo-8 as the indicator. When these cells were irradiated with 808 nm laser for 2 s, there was a significant enhancement in the fluorescence intensity for SPN2bctreated but not for SPN1bc-treated ND7/23 cells. This can be attributed to the fact that the heating ability of SPN2bc was much faster and stronger than that of SPN1bc. Additionally, the SPN2bc demonstrated simultaneous input–output interrogation of neuronal cells within milliseconds in a safe and reversible manner. Overall, this work provides insight into the development of new organic system based on photothermal transducers to control the thermosensitive ion channels in neurons.\nTo further endow semiconducting polymers with the ability of both gene delivery and gene expression, Pu and co-workers designed a photothermal nanocarrier based on NIR absorbing dendronized semiconducting polymers (DSP). They utilized this for gene delivery and the remote activation of gene expression\nAdv. Healthcare Mater. 2019, 1801132\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (7 of 11)\nupon NIR light illumination (Figure 7).[16] DSP was synthesized via a graft-on method which consisted of the hydrophobic semiconducting backbone, polyamidoamine (PAMAM3) chains and poly(ethylene glycol) (PEG) blocks. DSP exhibited a broad absorption band centered at 635 nm with maximum fluorescence peaks at 791 nm, possessing NIR-induced fluorescence as well as heat. With respect to the photothermal performance, it was revealed that DSP could efficiently convert 808 nm laser energy to heat with a photothermal conversion efficiency as high as 44.2 ± 2.8% and that it had excellent photothermal stability. In this work, the remote photothermal activation of gene express was realized in conjunction with a heat shock promoter (HSP70) through electrostatic attraction between the DSP and HSP70-regulated gene. When the complex was delivered into the cells, the genetic material was separated from the DSP and entered the nucleus. Under the irradiation of 808 nm laser, the DSP was able to transduce laser energy to local heat to promote the transformation of the heat shock factor from monomers to trimers, and the trimers then enter the nucleus to bind to the heat shock element (HSE), thus activating the gene expression to obtain function proteins.\nThe capacity of DSP for gene expression was further investigated by using HeLa cells transfected with luciferase (pSV40-Luc) as the reporter gene, and the transfection efficacy was determined by the expression level of the luciferase. The bioluminescence intensity went up with the increase of nitrogen/phosphate (N/P) ratios and achieved maximum value at N/P = 7.5:1, showing the excellent transfection ability of DSP. Furthermore, enhanced green fluorescence protein\n(EGFP) was cloned downstream of HSP70, thus HeLa cells treated with DSP/pHSP70-EGFP or DSP/pHSP70-Luc at the optical N/P ratio of 7.5:1 were tested. The in vitro and in vivo results confirmed that the activation was only triggered by DSP-mediated photothermal transduction under the laser irradiation. Importantly, it was highlighted that the photothermal effect of DSP can quickly activate gene expression with 25-fold increases in the expression levels in living cells in comparison to that without irradiation. However, for the in vivo activation of gene expression, the efficacy of gene expression significantly decreased to be 4.5-fold in mice. The decrease suggests the possible limitations of the present DSP in vivo; thereby, DSP should be further modified regarding chemical structures and targeting ability. This research offers a solid proof of concept that the polymeric approach can be utilized to combine gene delivery and NIR-induced photothermal activation of gene expression.\nConjugated polymer nanoparticles (CPNs) with NIR absorption and emission have been prepared through the precise design of the donor-acceptor backbone structures, and they have been widely used in the biological field due to their good tissue-penetration ability and low phototoxicity. Wang et al. developed NIR-responsive CPNs by rapidly coprecipitating conjugated polymer PDPP-DBT and DSPE-PEG-MAL. They further modified with the positive charge Tat peptide, which could assist in the interaction between CPNs and cells (Figure 8).[17] The resultant CPNs-Tat was observed to have a strong absorption band from 600 to 900 nm, and to exhibit rapid and superior photothermal conversion capacity and high\nAdv. Healthcare Mater. 2019, 1801132\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (8 of 11)\nbiocompatibility. Similarly, HSP70 was employed as the heat shock promoter, and the EGFP gene was selected as the target gene. In order to confirm that the heat-induced gene expression is able to be activated by CPNs-Tat in living cells, HeLa cells transfected with pCDNA3.1-HSP-70-EGFP were incubated with CPNs-Tat at various concentration levels and then exposed to 808 nm laser irradiation. The cells treated with 20 µg mL-1 of CPNs-Tat exhibited rapid temperature elevation up to ≈42 °C, high enough to activate pCDNA3.1-HSP-70-EGFP and EGFP gene expression, such that the green fluorescence of cells was only observed when the concentration of CPNs-Tat was higher than 20 µg mL-1. Moreover, only CPNs-Tat transfected cells exhibited strong green fluorescence under irradiation in comparison to no green fluorescence for laser or CPNs-Tat alone. Such results validated that CPNs-Tat can produce sufficient heat to trigger the HSP70 promoter to start the transcription of the downstream EGFP gene, thus producing green fluorescent protein in the living cells. This work demonstrated the feasibility of the remote control of intracellular gene expression through NIR-induced photothermal activation of CPNs system, in which the downstream gene can be extended to any gene of interest. It is worth noting that in the cases of DSP and CPNs, heat shock protein mediated gene expression is transient, which differs from the more stable genetic transformation in classical optogenetic approaches. In addition, such a high laser intensity and long irradiation time may lead to undesirable temperature elevation and uncontrollable heat diffusion. Thus, the effect of overheating on cells is expected to be further investigated, and the laser intensity and exposure time may be further considered to achieve the effective heatinduced gene expression with minimal side effect to cells.\nAdv. Healthcare Mater. 2019, 1801132\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (9 of 11)"
    }, {
      "heading" : "4. Conclusions and Perspectives",
      "text" : "This review has provided a summary of some key recent progress with respect to NIR-activatable optogenetic nanoparticle tools that can activate or inhibit cellular signaling pathways. These nanoparticle systems include photon UCNPs and photothermal conversion nanoparticles. The deeptissue-penetration ability of NIR light endows these optogenetic tools with unique features, such as low invasiveness, minimal photodamage, and high spatiotemporal resolution. Although\nAdv. Healthcare Mater. 2019, 1801132\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (10 of 11)\nthe impact of these NIR-activatable optogenetic tools has already been demonstrated, challenges remain in biomedical study and future clinical translation.\nFor UCNP-mediated optogenetic tools, several key issues require much deeper investigation. Firstly, biosafety concerns brought by these inorganic UCNPs remain, especially with respect to long-term biocompatibility. The effect of the chemical composition, size, and surface modification of UCNPs on nanotoxicity profiles requires systematic investigation on the cellular, tissue, and organ levels. Secondly, the intrinsic low absorption and emission cross sections of lanthanide ions result in suboptimal quantum yields of inorganic UCNPs. Strategies to develop alternative, brighter UCNPs, such as emerging organic-chromophore-based triplet–triplet annihilation upconversion nanoparticles (TTA-UCNPs), which has shown much improved quantum yield and biocompatibility, will be explored.[7e] In principle, low-power infrared light emitting diodes, rather than coherent laser beams, can be readily used as the excitation light source for TTA-UCNPs. Moreover, these organic UCNPs can mitigate the issue of metal ion induced toxicity due to their biodegradability. Thirdly, the lack of cell specific targeting capability also hinders the application of UCNP-mediated optogenetic tools. Emerging genomeengineering techniques can be used to specifically control endogenous gene transcription in the targeted group of cells. Thus in the future, to further pursue higher specificity, different recombinases (e.g., Cre and Flp) using anatomical and/ or genetic criteria can be combined to restrict opsin expression to specific cell types. In parallel, since new optogenetic protein constructs and thermosensitive proteins have been continuously discovered or synthesized, nanoparticles are thus expected to be optimized or reinvented to adapt to such progress. Thus, these new versions of UCNPs are expected to be optimized to enable ion-selectivity (such as Ca2+, Na+, and K+) and more effective cell-specific manipulation. Fourthly, opto genetic tools should be modified with the ability of\nAdv. Healthcare Mater. 2019, 1801132\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1801132 (11 of 11)\novercoming blood-brain barrier (BBB) for deep brain stimulation in vivo. Thus UCNPs can be injected intravenously rather than the current used more invasive stereotactic manner. Extensive studies should be expected to be done to solve these fundamental problems for the development of better UCNPmediated optogenetic tools.\nIn terms of NIR-induced photothermal wireless light activation tools, the current research also suffers from certain limitations. Unlike the instant response of UCNP-mediated optogenetic tools, it takes longer time to response to allow the temperature to elevate to a required degree. Therefore, it is highly important to improve the photothermal conversion efficacy of NIR absorbers which can be influenced by further controlling their size, morphology, and composition. For example, the absorption peak of Au nanorods is aspect-ratio-dependent, and this can be dynamically tuned from ≈650 nm to 1000 nm. In addition, some recent NIR absorbers have been reported to have broad absorption that extends to the biological NIR-II transparency window (1000– 1350 nm), perhaps offering more efficient tissue penetration relative to the currently used NIR-I window (650–950 nm).[7c] Additionally, the laser power density and exposure time are critical and should be carefully regulated during photothermal-activation, reducing side effects of photothermal overheating. Importantly, the mechanism of photothermalactivation is not clearly stated in current research. Therefore, the upcoming research is expected to focus on developing emerging photothermal-activated tools with high sensitivity and understanding the mechanism.\nFurthermore, we also anticipate the development of improved targeting strategies. In particular, antibody conjugation may be explored in order to improve specific tissue targeting and activation/inhibition precision in a superior spatiotemporal manner. The emerging genome-engineering techniques also can be used to control endogenous gene transcription. Since new optogenetic opsin protein constructs and thermosensitive proteins have continually been discovered or synthesized, nanoparticles are thus expected to be optimized or reinvented to adapt to such progress. Overall, these NIRactivatable optogenetic nanoparticles can pave the way to uncover the many cell functions that are currently inaccessible to the existing technologies. They may lead to innovative types of photomedicine and therapy for diseases in the near future."
    }, {
      "heading" : "Acknowledgements",
      "text" : "This research was supported by a grant from the China Scholarship Council (CSC) to N.Y. This research was supported by the National Institutes of Health (Grant no. R21GM126532 to G.H. and Y.Z.), the Human Frontier Science Program (Grant no. RGY-0090/2014) to G.H. and T.X., and also National Natural Science Foundation of China (81790644 and 31322024) to T.X."
    }, {
      "heading" : "Conflict of Interest",
      "text" : "The authors declare no conflict of interest."
    }, {
      "heading" : "Keywords",
      "text" : "nanomaterials, near infrared, optogenetics, photothermal, upconversion\nReceived: September 11, 2018 Revised: December 1, 2018\nPublished online:\n[1] a) R. H. Kramer, A. Mourot, H. Adesnik, Nat. Neurosci. 2013, 16, 816; b) B. Fan, W. Li, Lab Chip 2015, 15, 3838; c) K. Zhang, B. Cui, Trends Biotechnol. 2015, 33, 92. [2] R. L. Fork, Science 1971, 171, 907. [3] G. Nagel, T. Szellas, W. Huhn, S. Kateriya, N. Adeishvili, P. Berthold,\nD. Ollig, P. Hegemann, E. Bamberg, Proc. Natl. Acad. Sci. 2003, 100, 13940. [4] J. G. McCall, T. I. Kim, G. Shin, X. Huang, Y. H. Jung, R. Al-Hasani, F. G. Omenetto, M. R. Bruchas, J. A. Rogers, Nat. Protoc. 2013, 8, 2413. [5] J. Y. Lin, P. M. Knutsen, A. Muller, D. Kleinfeld, R. Y. Tsien, Nat. Neurosci. 2013, 16, 1499. [6] Q. W. Tian, F. R. Jiang, R. J. Zou, Q. Liu, Z. G. Chen, M. F. Zhu, S. P. Yang, J. L. Wang, J. H. Wang, J. Q. Hu, ACS Nano 2011, 5, 9761. [7] a) L. Cheng, C. Wang, L. Feng, K. Yang, Z. Liu, Chem. Rev. 2014, 114, 10869; b) W. P. Fan, P. Huang, X. Y. Chen, Chem. Soc. Rev. 2016, 45, 6488; c) N. Yu, Y. Hu, X. Wang, G. Liu, Z. Wang, Z. Liu, Q. Tian, M. Zhu, X. Shi, Z. Chen, Nanoscale 2017, 9, 9148; d) N. Yu, Z. Wang, J. Zhang, Z. Liu, B. Zhu, J. Yu, M. Zhu, C. Peng, Z. Chen, Biomaterials 2018, 161, 279; e) L. Huang, Y. Zhao, H. Zhang, K. Huang, J. Yang, G. Han, Angew. Chem., Int. Ed. 2017, 129, 14592; f) L. Huang, Z. Li, Y. Zhao, J. Yang, Y. Yang, A. I. Pendharkar, Y. Zhang, S. Kelmar, L. Chen, W. Wu, J. Zhao, G. Han, Adv. Mater. 2017, 29, 1604789. [8] A. Pliss, T. Y. Ohulchanskyy, G. Chen, J. Damasco, C. E. Bass, P. N. Prasad, ACS Photonics 2017, 4, 806. [9] a) A. Z. W. Shuo Chen, X. Zeng, L. He, X. Wang, J. Y. H. Yanqiu Tao, Y. Hashimotodani, M. Kano, L. K. P. Hirohide Iwasaki, S. Okabe, D. B. L. Teh, I. T.-K. Angelo, H. All, K. F. Tanaka, X. Liu, T. J. McHugh, Science 2018, 359, 679; b) G. Chen, H. Qiu, P. N. Prasad, X. Chen, Chem. Rev. 2014, 114, 5161. [10] X. Wu, Y. W. Zhang, K. Takle, O. Bilsel, Z. J. Li, H. Lee, Z. J. Zhang, D. S. Li, W. Fan, C. Y. Duan, E. M. Chan, C. Lois, Y. Xiang, G. Han, ACS Nano 2016, 10, 1060. [11] L. He, Y. Zhang, G. Ma, P. Tan, Z. Li, S. Zang, X. Wu, J. Jing, S. Fang, L. Zhou, Y. Wang, Y. Huang, P. G. Hogan, G. Han, Y. Zhou, eLife 2015, 4, 10024. [12] a) Z. G. Chen, Q. Wang, H. L. Wang, L. S. Zhang, G. S. Song, L. L. Song, J. Q. Hu, H. Z. Wang, J. S. Liu, M. F. Zhu, D. Y. Zhao, Adv. Mater. 2013, 25, 2095; b) Q. W. Tian, M. H. Tang, Y. G. Sun, R. J. Zou, Z. G. Chen, M. F. Zhu, S. P. Yang, J. L. Wang, J. H. Wang, J. Q. Hu, Adv. Mater. 2011, 23, 3542; c) E. C. Dreaden, M. A. Mackey, X. H. Huang, B. Kang, M. A. El-Sayed, Chem. Soc. Rev. 2011, 40, 3391. [13] A. Ambrosone, V. Marchesano, S. Carregal-Romero, D. Intartaglia, W. J. Parak, C. Tortiglione, ACS Nano 2016, 10, 4828. [14] L. J. Bugaj, A. T. Choksi, C. K. Mesuda, R. S. Kane, D. V. Schaffer, Nat. Methods 2013, 10, 249. [15] Y. Lyu, C. Xie, S. A. Chechetka, E. Miyako, K. Pu, J. Am. Chem. Soc. 2016, 138, 9049. [16] Y. Lyu, D. Cui, H. Sun, Y. Miao, H. Duan, K. Pu, Angew. Chem., Int. Ed. 2017, 56, 9155. [17] Y. Wang, S. Li, P. Zhang, H. Bai, L. Feng, F. Lv, L. Liu, S. Wang, Adv. Mater. 2018, 30, 1705418.\nAdv. Healthcare Mater. 2019, 1801132"
    } ],
    "references" : [ ],
    "referenceMentions" : [ ],
    "year" : 2019,
    "abstractText" : "Optogenetics is an emerging technology that uses genetically encoded proteins to dissect cellular functions, gene expression, and protein interaction, opening new opportunities for the study of brain mapping, retinal prosthesis, and neuronal disorders (e.g., Parkinson’s disease) that cannot be satisfactorily achieved by conventional pharmacological and genetic modality.[1] Optogenetic tools are blessed with exceptional spatiotemporal precision and sensitivity through light-controlled intracellular signal transduction, as the light can be turned on or off instantaneously and can also be directed to specific subcellular locations with tunable wavelength and intensity. One prerequisite to the practice of optogenetics is to develop various kinds of optogenetic tools. In 1971, action potential simulation in Aplysia ganglia were first demonstrated using a high power blue laser.[2] In 2003, a great breakthrough for optogenetic control of mammalian neurons was achieved use of a light-sensitive ion channel, Channelrhodopsin-2 (ChR2).[3] Unfortunately, these optogenetic tools usually rely on visible light (e.g., blue or yellow) with shallow tissue penetration, thus requiring the insertion of invasive fiber-optic probes into organs and tissues for signal stimulation in animals. Further attempts include the implantation of micro light-emitting diodes (μ-LEDs) inside tissue,[4] and the design of a red-shifted variant of channelrhodopsin (ReaChR),[5] which are still not ideal in regard to limitations related to penetration depth and safety issues. Therefore, it is highly desirable to develop optogenetic tools with an excitation wavelength that possesses much deeper tissue penetration ability and biocompatibility. Near-infrared (NIR) light with the wavelength of 700–1000 nm has been considered to be a biological transparency window that exhibits greater tissue penetration depth and minimal photodamage to tissue since such light has less absorption and less scattering within biological tissue.[6] Given these advantages, NIR-responsive molecules, organic polymers, and inorganic nanomaterials have been designed and synthesized, and these materials consequently have a variety of bioapplications, ranging from bioimaging (such as optical and photoacoustic imaging), therapies (photothermal therapy, photodynamic therapy, and so on), to that of controlled drug Optogenetics has been developed to control the activities and functions of cells with high spatiotemporal resolution, cell-type specificity, and flexibility. However, current optogenetic tools generally rely on visible light (e.g., blue or yellow) with shallow tissue penetration ability that does require invasive fiber-optic probes to deliver visible light into organs and animal tissues. This often results in a series of side effects, such as tissue damage and unwanted inflammation. Fortunately, the emerging wireless optogenetic tools that can respond to deep-tissue-penetrating near-infrared (NIR) light have attracted increasing attention due to their much-reduced damage to living organisms. There are mainly two types of NIR-activatable optogenetic tools: one uses lanthanide-doped upconversion nanoparticles to transduce NIR light to visible light to modulate classical opsin-expressing neurons; the other type couples with an NIR absorber to convert NIR light to heat to activate thermosensitive proteins. These NIR-activatable optogenetic tools enable low-invasive “remote control” activation and inhibition of cellular signaling pathways. This approach has great potential to help create more innovative therapies for diseases like cancer, diabetes, and neuronal disorders in the near future. Therefore, this review article summarizes the recent advances on design strategies and synthetic methods of NIR-activatable nanomaterials for wireless optogenetic applications. Wireless Optogenetics",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}